HAEMONETICS CORP — Director's Dealing 2011

Jun 7, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2011-06-03

Reporting Person: MEELIA RICHARD J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-06-03	Common Stock	A	2275.0	$0.01	Acquired	2275.0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-03	Non-Qualified Stock Option (right to buy)	$65.92	A	8484.0	Acquired	2018-06-03	Common Stock (8484.0)	Direct

Footnotes

F1: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.

F2: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.